Numerous clinical studies have found transcranial magnetic stimulation (TMS) therapy to be:
The Food and Drug Administration (FDA) has approved TMS for the treatment of depression and obsessive-compulsive disorder (OCD).
The treatment is currently used at some of the most trusted and respected hospitals, clinics, and universities in North America.
All major health insurance companies cover TMS therapy. Learn more about insurance coverage here.
TMS proves to be an effective therapy for major depression in this multisite observational report
Open-label, evidence-based analysis finds TMS to be an effective and long-lasting depression treatment.
Study determines TMS therapy is effective, safe, and free of major side effects.
Study shows that high doses of rTMS (repetitive transcranial magnetic stimulation) is safe and can produce rapid reductions in suicidality.